<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34514519</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-8798</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch Virol</ISOAbbreviation></Journal><ArticleTitle>Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.</ArticleTitle><Pagination><MedlinePgn>3117-3126</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-021-05223-7</ELocationID><Abstract><AbstractText>Evidence supports a role of host genetic diversity in the clinical course of coronavirus disease 2019 (COVID-19). Variation in the cannabinoid CB2 receptor gene (CNR2) could affect the regulatory action of endocannabinoids on the immune system, resulting in an increased risk of various inflammatory diseases. The present study investigated the relationship between the CNR2-Q63R variant and COVID-19 severity. A total of 200 Iranian COVID-19 patients were enrolled in the study and genotyped using a TaqMan assay. The co-dominant, dominant, recessive, over-dominant, and additive inheritance models were analyzed using SNPStats software. In silico molecular docking was also performed to simulate the effects of the Q63R variation on CB2 binding with a ligand and with the G-protein. A significant difference in the Q63R allele and genotype distribution was found between expired and discharged COVID-19 patients in co-dominant, recessive, and additive inheritance models. The molecular docking results showed that the predicted structure of mutant CB2 (63R type) could not bind to the G-protein in the correct position. The data indicated that the Q63R variation in the CNR2 gene may affect the severity of COVID-19. Identification of genes related to susceptibility and severity of COVID-19 may lead to specific targets for drug repurposing or development.</AbstractText><CopyrightInformation>© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rastegar</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samadizadeh</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasaghi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moradi</LastName><ForeName>Abdolvahab</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabarraei</LastName><ForeName>Alijan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salimi</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahamtan</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7680-5698</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran. Dr.tahamtan@goums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Dr.tahamtan@goums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C588309">CNR2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043885">Receptor, Cannabinoid, CB2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D019204">GTP-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019204" MajorTopicYN="N">GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043885" MajorTopicYN="N">Receptor, Cannabinoid, CB2</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>07</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>13</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34514519</ArticleId><ArticleId IdType="doi">10.1007/s00705-021-05223-7</ArticleId><ArticleId IdType="pii">10.1007/s00705-021-05223-7</ArticleId><ArticleId IdType="pmc">PMC8435402</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395(10223):470–473</Citation><ArticleIdList><ArticleId IdType="pubmed">31986257</ArticleId><ArticleId IdType="pmcid">7135038</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)30185-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513</Citation><ArticleIdList><ArticleId IdType="pubmed">7135076</ArticleId><ArticleId IdType="pmcid">7135076</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Teymoori-Rad M, Samadizadeh S, Tabarraei A, Moradi A, Shahbaz MB, Tahamtan A (2020) Ten challenging questions about SARS-CoV-2 and COVID-19. Expert Rev Respir Med 14:881–888</Citation><ArticleIdList><ArticleId IdType="pubmed">32536226</ArticleId><ArticleId IdType="doi">10.1080/17476348.2020.1782197</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A et al (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region Italy. Jama 323(16):1574–1581</Citation><ArticleIdList><ArticleId IdType="pubmed">32250385</ArticleId><ArticleId IdType="pmcid">7136855</ArticleId><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif-Askari NS, Sharif-Askari FS, Alabed M, Temsah M-H, Al Heialy S, Hamid Q et al (2020) Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol Ther Methods Clin Dev 18:1–6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2020.05.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams FM, Freydin M, Mangino M, Couvreur S, Visconti A, Bowyer RC et al (2020) Self-reported symptoms of covid-19 including symptoms most predictive of SARS-CoV-2 infection, are heritable. medRxiv 6:e1000849</Citation></Reference><Reference><Citation>Zhao J, Yang Y, Huang H-P, Li D, Gu D-F, Lu X-F et al (2020) Relationship between the ABO blood group and the COVID-19 susceptibility. medRxiv 29:90</Citation></Reference><Reference><Citation>Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W et al (2020) Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 182(4):812–27.e19</Citation><ArticleIdList><ArticleId IdType="pubmed">32697968</ArticleId><ArticleId IdType="pmcid">7332439</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.06.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Yan L-M, Wan L, Xiang T-X, Le A, Liu J-M et al (2020) Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 20:656–657</Citation><ArticleIdList><ArticleId IdType="pubmed">32199493</ArticleId><ArticleId IdType="pmcid">7158902</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(20)30232-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J, Mu L, Huang J, Yu S, Chen B, Yin J (2005) An initial investigation of the association between the SARS outbreak and weather: with the view of the environmental temperature and its variation. J Epidemiol Community Health 59(3):186–192</Citation><ArticleIdList><ArticleId IdType="pubmed">15709076</ArticleId><ArticleId IdType="pmcid">1733040</ArticleId><ArticleId IdType="doi">10.1136/jech.2004.020180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K, Fong DY-T, Zhu B, Karlberg J (2006) Environmental factors on the SARS epidemic: air temperature, passage of time and multiplicative effect of hospital infection. Epidemiol Infect 134(2):223–30</Citation><ArticleIdList><ArticleId IdType="pubmed">16490124</ArticleId><ArticleId IdType="doi">10.1017/S0950268805005054</ArticleId></ArticleIdList></Reference><Reference><Citation>Roxby AC, Greninger AL, Hatfield KM, Lynch JB, Dellit TH, James A et al (2020) Detection of SARS-CoV-2 among residents and staff members of an independent and assisted living community for older adults—Seattle, Washington, 2020. Morb Mortal Wkly Rep 69(14):416</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6914e2</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadizadeh S, Masoudi M, Rastegar M, Salimi V, Shahbaz MB, Tahamtan A (2021) COVID-19: why does disease severity vary among individuals? Respir Med 180:106356</Citation><ArticleIdList><ArticleId IdType="pubmed">33713961</ArticleId><ArticleId IdType="pmcid">7934673</ArticleId><ArticleId IdType="doi">10.1016/j.rmed.2021.106356</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A, Samadizadeh S, Rastegar M, Nakstad B, Salimi V (2020) Respiratory syncytial virus infection: why does disease severity vary among individuals? Expert Rev Respir Med 14(4):415–423</Citation><ArticleIdList><ArticleId IdType="pubmed">31995408</ArticleId><ArticleId IdType="doi">10.1080/17476348.2020.1724095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H-C, Mackie K (2016) An introduction to the endogenous cannabinoid system. Biol Psychiatry 79(7):516–525</Citation><ArticleIdList><ArticleId IdType="pubmed">26698193</ArticleId><ArticleId IdType="doi">10.1016/j.biopsych.2015.07.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A, Tavakoli-Yaraki M, Rygiel TP, Mokhtari-Azad T, Salimi V (2016) Effects of cannabinoids and their receptors on viral infections. J Med Virol 88(1):1–12</Citation><ArticleIdList><ArticleId IdType="pubmed">26059175</ArticleId><ArticleId IdType="doi">10.1002/jmv.24292</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A, Tavakoli-Yaraki M, Salimi V (2020) Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients. Expert Rev Respir Med 14(10):965–967</Citation><ArticleIdList><ArticleId IdType="pubmed">32576053</ArticleId><ArticleId IdType="doi">10.1080/17476348.2020.1787836</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi F, Tortora C, Argenziano M, Di Paola A, Punzo F (2020) Cannabinoid receptor type 2: a possible target in SARS-CoV-2 (CoV-19) infection? Int J Mol Sci 21(11):3809</Citation><ArticleIdList><ArticleId IdType="pmcid">7312493</ArticleId><ArticleId IdType="doi">10.3390/ijms21113809</ArticleId><ArticleId IdType="pubmed">7312493</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A, Samieipoor Y, Nayeri FS, Rahbarimanesh AA, Izadi A, Rashidi-Nezhad A et al (2018) Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice. Virulence 9(1):217–230</Citation><ArticleIdList><ArticleId IdType="pubmed">28992427</ArticleId><ArticleId IdType="doi">10.1080/21505594.2017.1389369</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A, Rezaiy S, Samadizadeh S, Moradi A, Tabarraei A, Javid N et al (2020) Cannabinoid CB2 receptor functional variation (Q63R) is associated with multiple sclerosis in Iranian subjects. J Mol Neurosci 70(1):26–31</Citation><ArticleIdList><ArticleId IdType="pubmed">31407233</ArticleId><ArticleId IdType="doi">10.1007/s12031-019-01395-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellini G, Olivieri AN, Grandone A, Alessio M, Gicchino M, Nobili B et al (2015) Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis. Scand J Rheumatol 44(4):284–287</Citation><ArticleIdList><ArticleId IdType="pubmed">25974389</ArticleId><ArticleId IdType="doi">10.3109/03009742.2015.1020863</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouda HM, Kamel NRM (2013) Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt. Blood Coag Fibrinol 24(3):247–251</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e32835aba1d</ArticleId></ArticleIdList></Reference><Reference><Citation>Strisciuglio C, Bellini G, Miele E, Martinelli M, Cenni S, Tortora C et al (2018) Cannabinoid receptor 2 functional variant contributes to the risk for pediatric inflammatory bowel disease. J Clin Gastroenterol 52(5):e37–e43</Citation><ArticleIdList><ArticleId IdType="pubmed">27875353</ArticleId><ArticleId IdType="doi">10.1097/MCG.0000000000000755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail M, Khawaja G (2018) Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis. Clin Rheumatol 37(11):2933–2938</Citation><ArticleIdList><ArticleId IdType="pubmed">30032418</ArticleId><ArticleId IdType="doi">10.1007/s10067-018-4217-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi F, Bellini G, Tolone C, Luongo L, Mancusi S, Papparella A et al (2012) The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. Pharmacol Res 66(1):88–94</Citation><ArticleIdList><ArticleId IdType="pubmed">22465144</ArticleId><ArticleId IdType="doi">10.1016/j.phrs.2012.03.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Wager-Miller J, Mackie K (2002) Cloning and molecular characterization of the rat CB2 cannabinoid receptor. Bioch Biophys Acta 1576(3):255–64</Citation></Reference><Reference><Citation>Carrasquer A, Nebane NM, Williams WM, Song Z-H (2010) Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor. Pharmacogenet Genomics 20(3):157–166</Citation><ArticleIdList><ArticleId IdType="pubmed">20124950</ArticleId><ArticleId IdType="doi">10.1097/FPC.0b013e3283367c6b</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipe JC, Arbour N, Gerber A, Beutler E (2005) Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol 78(1):231–238</Citation><ArticleIdList><ArticleId IdType="pubmed">15845647</ArticleId><ArticleId IdType="doi">10.1189/jlb.0205111</ArticleId></ArticleIdList></Reference><Reference><Citation>Solé X, Guinó E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22(15):1928–1929</Citation><ArticleIdList><ArticleId IdType="pubmed">16720584</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btl268</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5(4):725–738</Citation><ArticleIdList><ArticleId IdType="pubmed">2849174</ArticleId><ArticleId IdType="pmcid">2849174</ArticleId><ArticleId IdType="doi">10.1038/nprot.2010.5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10(6):845–858</Citation><ArticleIdList><ArticleId IdType="pubmed">25950237</ArticleId><ArticleId IdType="pmcid">25950237</ArticleId><ArticleId IdType="doi">10.1038/nprot.2015.053</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Zhang Y (2011) Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 101(10):2525–2534</Citation><ArticleIdList><ArticleId IdType="pubmed">22098752</ArticleId><ArticleId IdType="pmcid">3218324</ArticleId><ArticleId IdType="doi">10.1016/j.bpj.2011.10.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran GN, Ramakrishnan C, Sasisekharan V (1963) Stereochemistry of polypeptide chain configurations. J Mol Biol 7(1):95–99</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(63)80023-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC et al (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605–1612</Citation><ArticleIdList><ArticleId IdType="pubmed">15264254</ArticleId><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3(1):33</Citation><ArticleIdList><ArticleId IdType="pubmed">21982300</ArticleId><ArticleId IdType="pmcid">3198950</ArticleId><ArticleId IdType="doi">10.1186/1758-2946-3-33</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455–461</Citation><ArticleIdList><ArticleId IdType="pubmed">3041641</ArticleId><ArticleId IdType="pmcid">3041641</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Zhang D, Zhou P, Li B, Huang S-Y (2017) HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy. Nucleic Acids Res 45(W1):W365–W373</Citation><ArticleIdList><ArticleId IdType="pubmed">28521030</ArticleId><ArticleId IdType="pmcid">5793843</ArticleId><ArticleId IdType="doi">10.1093/nar/gkx407</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue LC, Rodrigues JP, Kastritis PL, Bonvin AM, Vangone A (2016) PRODIGY: a web server for predicting the binding affinity of protein–protein complexes. Bioinformatics 32(23):3676–3678</Citation><ArticleIdList><ArticleId IdType="pubmed">27503228</ArticleId><ArticleId IdType="pmcid">27503228</ArticleId></ArticleIdList></Reference><Reference><Citation>Karadag E (2020) Increase in COVID-19 cases and case-fatality and case-recovery rates in Europe: a cross-temporal meta-analysis. J Med Virol 92(9):1511–1517</Citation><ArticleIdList><ArticleId IdType="pubmed">32437052</ArticleId><ArticleId IdType="doi">10.1002/jmv.26035</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux CA, Rolain JM, Raoult D (2020) ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect 53(3):425–435</Citation><ArticleIdList><ArticleId IdType="pubmed">32414646</ArticleId><ArticleId IdType="pmcid">7201239</ArticleId><ArticleId IdType="doi">10.1016/j.jmii.2020.04.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D et al (2020) Genetic mechanisms of critical illness in Covid-19. Nature 344:807</Citation></Reference><Reference><Citation>Klein TW, Newton C, Friedman H (1998) Cannabinoid receptors and immunity. Immunol Today 19(8):373–381</Citation><ArticleIdList><ArticleId IdType="pubmed">9709506</ArticleId><ArticleId IdType="doi">10.1016/S0167-5699(98)01300-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Karmaus PWF, Chen W, Crawford R, Kaplan BLF, Kaminski NE (2013) Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. Toxicol Sci 131(2):419–433</Citation><ArticleIdList><ArticleId IdType="pubmed">23152191</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfs315</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchweitz JP, Karmaus PW, Williams KJ, Harkema JR, Kaminski NE (2008) Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol. J Leukoc Biol 83(3):785–796</Citation><ArticleIdList><ArticleId IdType="pubmed">18073275</ArticleId><ArticleId IdType="doi">10.1189/jlb.0907618</ArticleId></ArticleIdList></Reference><Reference><Citation>Karmaus PWF, Chen W, Crawford RB, Harkema JR, Kaplan BLF, Kaminski NE (2011) Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection. J Leukoc Biol 90(5):983–995</Citation><ArticleIdList><ArticleId IdType="pubmed">21873455</ArticleId><ArticleId IdType="pmcid">3206470</ArticleId><ArticleId IdType="doi">10.1189/jlb.0511219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu J, Liu J, Zhu H, Peng Y, Ding Z-M et al (2018) Genetic variant Q63R of cannabinoid receptor 2 causes differential ERK phosphorylation in human immune cells. Genet Test Mol Biomarkers 22(5):320–326</Citation><ArticleIdList><ArticleId IdType="pubmed">29694791</ArticleId><ArticleId IdType="doi">10.1089/gtmb.2018.0005</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi F, Mancusi S, Bellini G, Roberti D, Punzo F, Vetrella S et al (2011) CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. Haematologica 96(12):1883–1885</Citation><ArticleIdList><ArticleId IdType="pubmed">21828121</ArticleId><ArticleId IdType="pmcid">3232275</ArticleId><ArticleId IdType="doi">10.3324/haematol.2011.045732</ArticleId></ArticleIdList></Reference><Reference><Citation>Strisciuglio C, Bellini G, Miele E, Martinelli M, Cenni S, Tortora C et al (2016) Cannabinoid receptor 2 functional variant contributes to the risk of pediatric inflammatory bowel disease. Digest Liver Dis 48:e269</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2016.08.076</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I et al (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34(2):327–331</Citation><ArticleIdList><ArticleId IdType="pubmed">32171193</ArticleId></ArticleIdList></Reference><Reference><Citation>Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4(11):873–884</Citation><ArticleIdList><ArticleId IdType="pubmed">14595399</ArticleId><ArticleId IdType="doi">10.1038/nrn1247</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao B, Mackie K (2009) Endocannabinoid receptor pharmacology. Curr Top Behav Neurosci 1:37–63</Citation><ArticleIdList><ArticleId IdType="pubmed">21104379</ArticleId><ArticleId IdType="doi">10.1007/978-3-540-88955-7_2</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P (2010) Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology 215(8):598–605</Citation><ArticleIdList><ArticleId IdType="pubmed">19457575</ArticleId><ArticleId IdType="doi">10.1016/j.imbio.2009.04.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A, Tavakoli-Yaraki M, Shadab A, Rezaei F, Marashi SM, Shokri F et al (2018) The role of cannabinoid receptor 1 in the immunopathology of respiratory syncytial virus. Viral Immunol 31(4):292–298. https://doi.org/10.1089/vim.2017.0098</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2017.0098</ArticleId><ArticleId IdType="pubmed">29461930</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>